HRA Pharma Sharpens Focus On OTC With Rare Diseases Split
By shifting its rare diseases portfolio into a newly-created affiliate, HRA Pharma is signalling its intention to become a force in the global consumer healthcare market.
You may also be interested in...
HRA is putting feet on the ground in China as it looks to establish itself in the world second-largest consumer health market.
France's HRA is looking to tap into consumer demand for foot care products in the Middle East by rolling out its Compeed brand in select markets across the region.
HRA Pharma reports impressive sales growth in 2018, thanks largely to acquisitions. A drop in demand for homeopathic medicines hurts Boiron in Q1, while Ipsen enjoys a solid start to the year.